Ovarian Cancer
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
BRCA: Who Should Be Tested?Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
-
Our Own WordsPeople with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
Finding Support in Unlikely PlacesAfter her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
-
Advocacy Spotlight: Sorting Out PrioritiesOvarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Survivor Profile
Going Full BoreSusan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
-
Forward Look
Little Consensus on Ovarian Cancer MonitoringTests and scans may be overused.
by Kate Yandell
-
Forward Look
Identifying Ovarian Cancer RiskStudy may help spotlight women who would benefit from risk reduction strategies.
by Carrie Printz
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
First Person
Never Alone: A Family JourneyA mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment.
by Mary (Dicey) Jackson Scroggins and Nneka Scroggins
